1. Home
  2. SLGL vs CAQ Comparison

SLGL vs CAQ Comparison

Compare SLGL & CAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$73.50

Market Cap

247.1M

Sector

Health Care

ML Signal

N/A

CAQ

Cambridge Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.91

Market Cap

248.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGL
CAQ
Founded
1997
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
248.2M
IPO Year
2016
2026

Fundamental Metrics

Financial Performance
Metric
SLGL
CAQ
Price
$73.50
$9.91
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$110.00
N/A
AVG Volume (30 Days)
28.4K
4.1K
Earning Date
05-22-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$223.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.96
$9.90
52 Week High
$97.97
$9.91

Technical Indicators

Market Signals
Indicator
SLGL
CAQ
Relative Strength Index (RSI) 51.77 N/A
Support Level $66.85 N/A
Resistance Level $75.00 N/A
Average True Range (ATR) 5.47 0.00
MACD -0.11 0.00
Stochastic Oscillator 42.45 0.00

Price Performance

Historical Comparison
SLGL
CAQ

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About CAQ Cambridge Acquisition Corp. Class A Ordinary Shares

Cambridge Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: